MIMEDX EPIFIX® Receives Reimbursement Approval in Japan
Provides Favorable Access to a New $500 Million Market for the Treatment of Refractory Diabetic and Venous Ulcers for EPIFIX – the First and Only Amniotic...
Hilary Dixon Jack Howarth Takanori Kuramoto Hiroto Terashi Rohit Kashyap Japanese Ministry Of Health
Source: globenewswire.com